TARTAGLIONE, Immacolata
 Distribuzione geografica
Continente #
EU - Europa 3.069
NA - Nord America 1.249
AS - Asia 1.188
SA - Sud America 214
AF - Africa 28
OC - Oceania 2
Totale 5.750
Nazione #
RU - Federazione Russa 2.130
US - Stati Uniti d'America 1.223
SG - Singapore 434
IE - Irlanda 298
IT - Italia 262
CN - Cina 247
HK - Hong Kong 207
BR - Brasile 176
VN - Vietnam 126
DE - Germania 105
GB - Regno Unito 86
KR - Corea 51
JP - Giappone 32
IN - India 31
UA - Ucraina 30
FR - Francia 28
GR - Grecia 22
FI - Finlandia 20
AR - Argentina 17
AT - Austria 15
SE - Svezia 15
NL - Olanda 13
PK - Pakistan 13
CA - Canada 12
BD - Bangladesh 11
MX - Messico 11
BE - Belgio 10
ZA - Sudafrica 10
TR - Turchia 9
CH - Svizzera 8
ES - Italia 7
VE - Venezuela 7
ID - Indonesia 6
EC - Ecuador 5
CO - Colombia 4
DZ - Algeria 4
IL - Israele 4
CL - Cile 3
MA - Marocco 3
PL - Polonia 3
TN - Tunisia 3
UZ - Uzbekistan 3
AU - Australia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IQ - Iraq 2
JO - Giordania 2
NI - Nicaragua 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
SN - Senegal 1
TW - Taiwan 1
Totale 5.750
Città #
Moscow 785
Dublin 289
Hong Kong 204
Singapore 203
Santa Clara 171
San Jose 140
Chandler 122
Ashburn 72
Jacksonville 66
Seoul 50
Beijing 48
Caserta 43
New York 43
Princeton 38
Roxbury 38
Ann Arbor 36
Hanoi 35
Ho Chi Minh City 35
Bremen 33
Hefei 33
Naples 33
Munich 32
Dallas 22
Grumo Nevano 21
Cambridge 20
Ercolano 20
Bengaluru 19
Medford 19
The Dalles 17
Wilmington 17
Woodbridge 17
Los Angeles 15
Des Moines 13
São Paulo 13
Nuremberg 12
Da Nang 11
Helsinki 11
Nanjing 11
Boardman 10
Brussels 10
Milan 10
Rome 10
Vienna 10
London 9
Amsterdam 8
Johannesburg 8
Napoli 8
Pozzuoli 8
Falkenstein 7
Haiphong 7
Redwood City 7
Belo Horizonte 6
Brooklyn 6
Montreal 6
Nanchang 6
Orem 6
Shanghai 6
Turku 6
Atlanta 5
Biên Hòa 5
Hillsboro 5
Orlando 5
Rio de Janeiro 5
Bologna 4
Brasília 4
Campinas 4
Curitiba 4
Fairfield 4
Lahore 4
Salvador 4
San Mateo 4
Stockholm 4
Taizhou 4
Tokyo 4
Afragola 3
Aversa 3
Boston 3
Chicago 3
Guangzhou 3
Istanbul 3
Manchester 3
Mexico City 3
Poplar 3
Quito 3
Ribeirão Preto 3
Shenyang 3
Takoma Park 3
Tashkent 3
Tel Aviv 3
Thái Nguyên 3
Tianjin 3
Abidjan 2
Ankara 2
Araraquara 2
Asunción 2
Bandung 2
Belgrade 2
Bogotá 2
Brno 2
Buenos Aires 2
Totale 3.099
Nome #
Effects of germline VHL deficiency on growth, metabolism, and mitochondria 215
Cognitive, Brain and Intracranial Artery Involvement in Beta Thalassemia 212
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload 172
Auditory cortex hypoperfusion: a metabolic hallmark in Beta Thalassemia 170
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 168
Asymptomatic intracranial aneurysms in beta-thalassemia: A three-year follow-up report 165
Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study 154
A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity 154
Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience 149
Genome editing and cancer therapy: handling the hypoxia-responsive pathway as a promising strategy 146
Brain functional impairment in beta-thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literature 145
BONE MINERAL DENSITY IMPROVEMENT IN PATIENTS WITH THALASSEMIA MAJOR ON LONG-TERM CHELATION THERAPY WITH DEFERASIROX 144
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort 142
No evidence of increased cerebrovascular involvement in adult neurologically-asymptomatic β-Thalassaemia. A multicentre multimodal magnetic resonance study 141
A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis 137
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multicentre nation-wide cohort 137
Childhood Multiple Endocrine Neoplasia (MEN) Syndromes: Genetics, Clinical Heterogeneity and Modifying Genes 136
An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research 129
Transient erythroblastopenia of childhood after COVID-19 infection: a case report 128
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort 128
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function 123
Headache in beta-thalassemia: An Italian multicenter clinical, conventional MRI and MR-angiography case-control study 122
Brain perfusion changes in beta-thalassemia 121
Crushed deferasirox film-coated tablets in pediatric patients with transfusional hemosiderosis: Results from a single-arm, interventional phase 4 study (MIMAS) 116
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 111
GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia 110
Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica) 107
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with beta-thalassemia. 103
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection 103
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-Thalassemia. 102
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia. 101
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 99
Hearing loss in beta-thalassemia: Systematic review 97
No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses 96
Hearing loss in beta-thalassaemia: An Italian multicentre case-control study 95
Cognitive impairment in hereditary spherocytosis 91
Two-year long safety and efficacy of deferasirox film-coated tablets in patients with thalassemia or lower/intermediate risk MDS: Phase 3 results from a subset of patients previously treated with deferasirox in the ECLIPSE study 91
White matter volume changes in adult beta-thalassemia: Negligible and unrelated to anemia and cognitive performances 90
Pain Burden in the CASiRe International Cohort of Sickle Cell Patients: United States and Ghana 90
Treatment of hepatitis C virus infection with direct-acting antiviral drugs is safe and effective in patients with hemoglobinopathies 85
Non-transfusion-dependent thalassemia in Italy: less blues, no role of reds 84
Treating Thalassemia Patients with Luspatercept: An Expert Opinion Based on Current Evidence 79
Risk factors for heart disease in transfusion-dependent thalassemia: serum ferritin revisited 76
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry 76
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia 75
Pregnancy and childbirth in women with thalassemia: past and present 75
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 74
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial 71
Renal safety under long-course deferasirox therapy in iron overloaded transfusion-dependent β-thalassemia and other anemias 67
Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain Crises 60
Disease Burden in Transfusion-Dependent β-Thalassemia (TDT) Patients and Caregivers in Italy: Results of a Cross-Sectional Descriptive Online Survey 8
Cerebrovascular involvement in hereditary spherocytosis: observational cohort and case-control MRI study 5
International variations in body mass index within the CASiRe global cohort of sickle cell disease patients 4
Identification of Novel Mutations in Patients Affected by Gaucher Disease 4
Totale 5.883
Categoria #
all - tutte 19.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.903


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 12 24 2
2021/2022279 6 4 5 4 61 10 31 25 18 7 20 88
2022/2023578 55 22 22 28 57 54 3 19 287 7 13 11
2023/2024235 19 7 18 14 63 47 4 5 5 0 19 34
2024/2025878 2 7 5 20 131 102 166 86 131 81 87 60
2025/20263.428 128 152 176 172 345 1.948 188 130 119 70 0 0
Totale 5.883